Lewis Nasr

9PUBLICATIONS
48CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|Jul 19, 2024
Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL.

Hagop Kantarjian, Nicholas J Short, Fadi G Haddad

|May 28, 2024
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.

Fadi G Haddad, Koji Sasaki, Lewis Nasr

|May 11, 2024
High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience.

Lewis F Nasr, Marianne Zoghbi, Rossana Lazcano

|Apr 12, 2024
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapy.

Nicholas J Short, Elias Jabbour, Lewis F Nasr

|Apr 09, 2024
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia.

Elias Jabbour, Fadi G Haddad, Koji Sasaki

Pageof 2

Frequent Collaborators

8 joint publications

Nicholas J Short

5 joint publications

Elias Jabbour

5 joint publications

Hagop Kantarjian

4 joint publications

Naval G Daver